Article (Scientific journals)
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study.
COVIDSurg Collaborative; GlobalSurg Collaborative; Khosravi, Mohammadhossein
2021In Anaesthesia, 76 (11), p. 1454 - 1464
Peer Reviewed verified by ORBi
 

Files


Full Text
COVIDSurg+Collaborative_Effects+of+pre-operative_2021.pdf
Author postprint (1.72 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
COVID-19; SARS-Cov-2; pathways; pre-operative isolation; surgery; Aged; Aged, 80 and over; COVID-19/epidemiology; COVID-19/prevention & control; Cohort Studies; Elective Surgical Procedures/adverse effects; Elective Surgical Procedures/trends; Female; Humans; Internationality; Lung Diseases/diagnosis; Lung Diseases/epidemiology; Male; Patient Isolation/trends; Postoperative Complications/diagnosis; Postoperative Complications/epidemiology; Preoperative Care/adverse effects; Preoperative Care/trends; Prospective Studies; Treatment Outcome; Elective Surgical Procedures; Lung Diseases; Patient Isolation; Postoperative Complications; Preoperative Care; Anesthesiology and Pain Medicine
Abstract :
[en] We aimed to determine the impact of pre-operative isolation on postoperative pulmonary complications after elective surgery during the global SARS-CoV-2 pandemic. We performed an international prospective cohort study including patients undergoing elective surgery in October 2020. Isolation was defined as the period before surgery during which patients did not leave their house or receive visitors from outside their household. The primary outcome was postoperative pulmonary complications, adjusted in multivariable models for measured confounders. Pre-defined sub-group analyses were performed for the primary outcome. A total of 96,454 patients from 114 countries were included and overall, 26,948 (27.9%) patients isolated before surgery. Postoperative pulmonary complications were recorded in 1947 (2.0%) patients of which 227 (11.7%) were associated with SARS-CoV-2 infection. Patients who isolated pre-operatively were older, had more respiratory comorbidities and were more commonly from areas of high SARS-CoV-2 incidence and high-income countries. Although the overall rates of postoperative pulmonary complications were similar in those that isolated and those that did not (2.1% vs 2.0%, respectively), isolation was associated with higher rates of postoperative pulmonary complications after adjustment (adjusted OR 1.20, 95%CI 1.05-1.36, p = 0.005). Sensitivity analyses revealed no further differences when patients were categorised by: pre-operative testing; use of COVID-19-free pathways; or community SARS-CoV-2 prevalence. The rate of postoperative pulmonary complications increased with periods of isolation longer than 3 days, with an OR (95%CI) at 4-7 days or ≥ 8 days of 1.25 (1.04-1.48), p = 0.015 and 1.31 (1.11-1.55), p = 0.001, respectively. Isolation before elective surgery might be associated with a small but clinically important increased risk of postoperative pulmonary complications. Longer periods of isolation showed no reduction in the risk of postoperative pulmonary complications. These findings have significant implications for global provision of elective surgical care.
Disciplines :
Surgery
Author, co-author :
COVIDSurg Collaborative
GlobalSurg Collaborative
Khosravi, Mohammadhossein  ;  Université de Liège - ULiège > GIGA > GIGA Consciousness - Coma Science Group
Language :
English
Title :
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study.
Publication date :
November 2021
Journal title :
Anaesthesia
ISSN :
0003-2409
eISSN :
1365-2044
Publisher :
John Wiley and Sons Inc, England
Volume :
76
Issue :
11
Pages :
1454 - 1464
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
NIHR - National Institute for Health Research [GB]
BDRF - Bowel Disease Research Foundation [GB]
Sarcoma UK [GB]
Urology Foundation [GB]
Funding text :
This trial was registered at clinicaltrials.gov (NCT04509986). Funding was provided by the: National Institute for Health Research (NIHR) Global Health Research Unit; Association of Coloproctology of Great Britain and Ireland; Bowel and Cancer Research; Bowel Disease Research Foundation; Association of Upper Gastrointestinal Surgeons; British Association of Surgical Oncology; British Gynaecological Cancer Society; European Society of Coloproctology; Medtronic, NIHR Academy; Sarcoma UK; Urology Foundation; Vascular Society for Great Britain and Ireland; and Yorkshire Cancer Research. The views expressed are those of the authors and not necessarily those of the funding partners. No other competing interests declared.
Available on ORBi :
since 29 December 2023

Statistics


Number of views
6 (0 by ULiège)
Number of downloads
5 (0 by ULiège)

Scopus citations®
 
35
Scopus citations®
without self-citations
35
OpenCitations
 
32

Bibliography


Similar publications



Contact ORBi